Beyond Medical Technologies: Enhancing Medical Operations with Blockchain Integration
Generado por agente de IAMarcus Lee
miércoles, 26 de febrero de 2025, 8:44 pm ET2 min de lectura
BYON--
Beyond Medical Technologies Inc. (CSE: DOCTDOCT--, OTC: DOCKF), a health technology company focused on advancing innovative solutions in the medical and technology sectors, has announced a strategic expansion into blockchain-powered medical technology and financial management. The company has entered into a non-binding letter of intent (LOI) with Elite Horizon Management, Inc. (Horizon), a blockchain attestation platform specializing in secure documentation and financial verification, to acquire 100% of Horizon's common shares. This proposed acquisition aims to integrate blockchain technology into Beyond Medical's operations, enhancing efficiency, security, and transparency in medical operations.

The proposed acquisition of Horizon is expected to be structured as a share exchange transaction, with Horizon shareholders receiving up to 11,250,000 common shares in the capital of Beyond MedicalBYON--. The transaction is subject to several conditions precedent, including satisfactory due diligence investigations, negotiation and execution of a definitive agreement by March 31, 2025, and receipt of all requisite regulatory and third-party approvals, including the approval of the Canadian Securities Exchange (CSE). Upon the execution of a definitive agreement, Beyond Medical will issue a subsequent press release containing the details of the Definitive Agreement and any additional terms of the Transaction.
In the event the Proposed Transaction is completed, 1167388 BC Ltd shall receive a finder's fee, payable in shares, equal to 7.5% of the value of the Proposed Transaction. Additionally, Beyond Medical has entered into a service agreement with Fairfax Partners Inc., a Vancouver, BC-based investor relations and marketing consultancy, to provide investor relations and marketing services to support the company's growth and shareholder communications. The contract commenced on February 6th and includes a setup fee of CAD $35,000 + GST (5%), with CAD $20,000 payable upon signing and CAD $15,000 at a later milestone. A monthly management fee of CAD $7,500 + GST (5%) will begin on the third month or at a mutually agreed time, running for 12 months and transitioning to a month-to-month basis thereafter. Additionally, a one-time marketing budget of CAD $50,000 + GST (5%) will cover social media campaigns (CAD $15,000) and digital ad campaigns (CAD $35,000) over a 12-month period.
By integrating Elite Horizon's blockchain technology, Beyond Medical aims to enhance its capabilities in tamper-proof medical documentation, compliance verification, and digital asset management. Horizon specializes in blockchain-based digital agreements, smart contract verification, and treasury management solutions, ensuring secure and verifiable digital records. This integration will enable Beyond Medical to improve compliance and verification processes in the medical technology industry, ultimately enhancing operational efficiency, security, and transparency.
In conclusion, Beyond Medical Technologies' proposed acquisition of Elite Horizon is a strategic move that aligns with the company's goal of improving patient outcomes and operational efficiencies through cutting-edge technology and strategic partnerships. By leveraging Horizon's blockchain-based digital agreements, smart contract verification, and treasury management solutions, Beyond Medical can enhance its medical technology and financial management capabilities, ultimately strengthening its position in the market.
DOCT--
Beyond Medical Technologies Inc. (CSE: DOCTDOCT--, OTC: DOCKF), a health technology company focused on advancing innovative solutions in the medical and technology sectors, has announced a strategic expansion into blockchain-powered medical technology and financial management. The company has entered into a non-binding letter of intent (LOI) with Elite Horizon Management, Inc. (Horizon), a blockchain attestation platform specializing in secure documentation and financial verification, to acquire 100% of Horizon's common shares. This proposed acquisition aims to integrate blockchain technology into Beyond Medical's operations, enhancing efficiency, security, and transparency in medical operations.

The proposed acquisition of Horizon is expected to be structured as a share exchange transaction, with Horizon shareholders receiving up to 11,250,000 common shares in the capital of Beyond MedicalBYON--. The transaction is subject to several conditions precedent, including satisfactory due diligence investigations, negotiation and execution of a definitive agreement by March 31, 2025, and receipt of all requisite regulatory and third-party approvals, including the approval of the Canadian Securities Exchange (CSE). Upon the execution of a definitive agreement, Beyond Medical will issue a subsequent press release containing the details of the Definitive Agreement and any additional terms of the Transaction.
In the event the Proposed Transaction is completed, 1167388 BC Ltd shall receive a finder's fee, payable in shares, equal to 7.5% of the value of the Proposed Transaction. Additionally, Beyond Medical has entered into a service agreement with Fairfax Partners Inc., a Vancouver, BC-based investor relations and marketing consultancy, to provide investor relations and marketing services to support the company's growth and shareholder communications. The contract commenced on February 6th and includes a setup fee of CAD $35,000 + GST (5%), with CAD $20,000 payable upon signing and CAD $15,000 at a later milestone. A monthly management fee of CAD $7,500 + GST (5%) will begin on the third month or at a mutually agreed time, running for 12 months and transitioning to a month-to-month basis thereafter. Additionally, a one-time marketing budget of CAD $50,000 + GST (5%) will cover social media campaigns (CAD $15,000) and digital ad campaigns (CAD $35,000) over a 12-month period.
By integrating Elite Horizon's blockchain technology, Beyond Medical aims to enhance its capabilities in tamper-proof medical documentation, compliance verification, and digital asset management. Horizon specializes in blockchain-based digital agreements, smart contract verification, and treasury management solutions, ensuring secure and verifiable digital records. This integration will enable Beyond Medical to improve compliance and verification processes in the medical technology industry, ultimately enhancing operational efficiency, security, and transparency.
In conclusion, Beyond Medical Technologies' proposed acquisition of Elite Horizon is a strategic move that aligns with the company's goal of improving patient outcomes and operational efficiencies through cutting-edge technology and strategic partnerships. By leveraging Horizon's blockchain-based digital agreements, smart contract verification, and treasury management solutions, Beyond Medical can enhance its medical technology and financial management capabilities, ultimately strengthening its position in the market.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios